$BLRX announces joint venture in China
BioLineRx (BLRX) and Chinese venture capital fund I-Bridge Capital have entered into a joint venture in China called iPharma which will develop therapeutic candidates originating primarily from...
View ArticleBiotech Trade Alerts Archive -2016-08-25- $MNK, $NVS, $PVCT, $VKTX, $BLRX,...
DRKKD.com Real Time Biotech Trade Alert Service August 25, 2016. Tickers covered: MNK, NVS, PVCT, VKTX, BLRX, KOOL, GALT, MYL, AMGN
View Article$BLRX launches mid-stage study of BL-8040 and Keytruda in pancreatic cancer
BioLineRx $BLRX started a Phase 2a study, COMBAT, evaluating a lead product candidate BL-8040 and Merck's $MRK KEYTRUDA (pembrolizumab), meant for curing metastatic pancreatic adenocarcinoma. The...
View Article$BLRX Shares Catapult after it Wins License for Liver Failure Treatment
Shares of BioLine Rx $BLRX surged in premarket hours amid high volume trading after it announced that it has inked an exclusive worldwide in-licensing agreement with BGN Technologies and Hadasit for a...
View Article
More Pages to Explore .....
